toxicity

July 31, 2017

Imbruvica Improves Quality of Life of Relapsed or Refractory Mantle Cell Lymphoma Patients, Trial Shows

News

Patients with relapsed or refractory mantle cell lymphoma have a better quality of life with Imbruvica (ibrutinib) than Torisel (temsirolimus), a Phase 3 clinical trial suggests. The finding was published in the journal Leukemia ... Read more

February 21, 2017

Delivering Lymphoma Chemotherapies with Platelets Could Reduce Adverse Effects, Study Reports

News

Using blood platelets to deliver lymphoma chemotherapies could reduce adverse effects of the treatment, according to a study. The use of natural cells such as platelets also could get around ... Read more

June 14, 2016June 14, 2016

New CAR T-Cell Lymphoma Therapy Aims to Kill Only Cancerous B-Cells

News

CAR T-cell therapies have revolutionized cancer treatment, but the method, used to target B-cell related cancers, has its drawbacks. Now, researchers have designed a new type of CAR cell that ... Read more

May 25, 2016May 25, 2016

Idelalisib for Indolent Non-Hodgkin Lymphoma a Viable Option, Review Finds

News

In a comprehensive review of idelalisib (Zydelig) treatment for patients with indolent non-Hodgkin lymphoma, Hofstra University’s Jacqueline C Barrientos concluded that the drug is a promising option in patients who have already been ... Read more

April 26, 2016April 26, 2016

Radiation’s Role in Hodgkin Lymphoma Challenged in Wake of Cancer Recurrence, Toxicity

News

A cover story on Healio.com’s current issue of the online publication HemOnc Today draws attention to the risks associated with radiation treatment for Hodgkin lymphoma — an issue that’s been a ... Read more

April 13, 2016September 8, 2016

PET Scans Can Guide Chemotherapy Choices for Hodgkin’s Lymphoma, Study Reports

News

A study published in the Journal of Clinical Oncology shows for the first time a chemotherapy regimen determination —made after a mid-point assessment of treatment — that successfully treats more patients with ... Read more